Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


All Eyes On China’s Medical Device Goldmine

This article was originally published in PharmAsia News

Executive Summary

To tap the enormous potential of China's medical device market, major MNCs such as GE, Siemens, Philips, Shimadzu and Toshiba have established footholds in the country, while continuing to pump in investment. According to industry figures, the total production value of China's medical devices will reach 100 billion yuan by 2010, accounting for 5 percent of the global market and making it the world's second largest market, overtaking Japan. To further dig into the huge goldmine, many MNCs have set up production and R&D bases to localize their products, manufacturing and sales. Research firm ChinaVenture reported that funding in the local health care sector topped this year's Q1 total capital investment at $83.99 million. (Click here for more - Chinese Language)

You may also be interested in...

Mediocre Vaccine Could Make Pandemic Worse, Non-Profit Group Tells US FDA

Comments ahead of the vaccine advisory committee ranged from public health groups opposed to emergency use authorizations, to industry requests for guidance on EUA labeling materials.

COVID-19 Concerns Could Enhance Ongoing Bloom Of Plant-Based Sports Nutrition Sales

"One of the issues that COVID-19 has brought out is, how safe is the production of animal-based food products?" 

Kyowa Kirin’s Parkinson’s Successor Shows Phase IIb Promise

Positive clinical results in Parkinson’s pave path forward for Japanese firm’s potential istradefylline successor.




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts